A novel method protects vaccines from heat degradation at RT for 3 yr

Heat degradation of the proteins in vaccines render these expensive and precious biomedical products ineffective. Scient...

June 11, 2020 | Thursday | News
MERS vaccine shows promise for COVID-19 vaccine development

A recent Phase I clinical trial performed at the University Medical Center Hamburg-Eppendorf for a Middle East respirato...

June 7, 2020 | Sunday | News
AstraZeneca Commits to 2 Billion Doses of COVID-19 Vaccine

UK-based AstraZeneca and the University of Oxford partnered on the global development and distribution ...

June 7, 2020 | Sunday | News
Novavax receives $60m from DOD to secure 10 million COVID-19 vaccine doses

Novavax commenced Phase I clinical trial for their COVID-19 vaccine "NVX-CoV2373" a stable prefusion protein antige...

June 7, 2020 | Sunday | News
INOVIO, IVI to start Ph 1/2 trials of COVID-19 vaccine in South Korea

US based INOVIO, the International Vaccine Institute (IVI), and Seoul National University Hospital have announ...

June 8, 2020 | Monday | News
University of Queensland, CEPI and CSL partner for COVID-19 vaccine

CEPI, the Coalition for Epidemic Preparedness Innovations, CSL and The University of Queensland (UQ) have announced that...

June 5, 2020 | Friday | News
CEPI awards Chikungunya vaccine "BBV87" $14.1 million

The Coalition for Epidemic Preparedness Innovations (CEPI) on 3 June 2020 announced a new partnering agreement to advanc...

June 3, 2020 | Wednesday | News
Chikungunya Vaccine Candidate 'VLA1553' set to enter Phase 3 Study

Chikungunya is considered to be a major public health threat by the World Health Organization. A speciality vaccine...

June 2, 2020 | Tuesday | News
Moderna Advances in Platform Science and Innovative Vaccine Research

Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to creat...

June 2, 2020 | Tuesday | News
Moderna finalizing protocol for Ph 3 study of COVID-19 vaccine

US based Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines...

June 4, 2020 | Thursday | News
Intravacc, EpiVax to develop novel COVID-19 vaccine

The Netherlands-based Intravacc, one of the world's leading translational research and development vaccine ins...

June 3, 2020 | Wednesday | News
IAVI, Merck to develop vaccine against SARS-CoV-2

Merck, known as MSD outside the United States and Canada, and IAVI, a nonprofit scientific research organization dedicat...

May 29, 2020 | Friday | News
Novavax begins Ph 1/2 trial of COVID-19 vaccine

US based Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious di...

May 28, 2020 | Thursday | News
Vaxine announces COVID-19 vaccine collaboration with Medytox

Vaxine Pty Ltd., Adelaide, Australia announced that it has entered into a formal collaboration with Medytox Inc., a Kore...

May 27, 2020 | Wednesday | News
PharmaJet, Abnova to use needle-free injection technology for COVID-19 vaccine

US based PharmaJet®, the maker of innovative, needle-free injection technology, has announced that its Needle-free I...

May 25, 2020 | Monday | News
Sinovac secures $15 M for COVID-19 vaccine development

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, has announced a transaction in which Ad...

May 25, 2020 | Monday | News
AGC Biologics partners with Takara Bio in COVID-19 fight

Denmark headquartered AGC Biologics, a global Contract Development and Manufacturing Organization (CDMO) for Biopharmace...

May 22, 2020 | Friday | News
Moderna's COVID-19 vaccine shows positive interim Ph 1 results

US based Moderna, Inc., a clinical-stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines...

May 20, 2020 | Wednesday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls